UNS
Click for more information
0.00% 0.5¢ unilife corporation

Co. Website., page-49

  1. Unifollower
    2,913 Posts.
    lightbulb Created with Sketch. 505
    clock Created with Sketch.
    15/03/17
    09:20
    Post #: 23352828
    More comfort reading

    Britain's medicines regulator has granted dupilumab a positive scientific opinion through its Early Access to Medicines Scheme, meaning patients can get the drug before it is granted formal marketing authorisation, Sanofi said on Tuesday.
    Dupilumab has impressed doctors in a series of clinical trials over the past year and consensus analyst forecasts already point to annual global sales of more than $4 billion by 2022

    http://uk.reuters.com/article/uk-sanofi-fr-regeneron-eczema-britain-idUKKBN16L0VF
    UNS Price at posting: 3.6¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

STX Strike reports flow test success at 100% owned Walyering-7
right-arrow Created with Sketch.
TG1 TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
right-arrow Created with Sketch.
POL Polymetals finalises acquisition of Endeavor silver-lead-zinc mine in NSW's Cobar Basin
right-arrow Created with Sketch.
MND Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
right-arrow Created with Sketch.
CKA Deal with Petrosea opens the door for Cokal's ramp-up plans in Indonesia
right-arrow Created with Sketch.
LML Lincoln repositions Kookaburra for low-cost graphite delivery
right-arrow Created with Sketch.
watchlist Created with Sketch. Add UNS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.